Submit Your Content

Ingenuity mixes with statistical expertise

by Quintiles Transnational Corp.

In this case study, Quintiles Transnational lowers the lost-to-followup (LTF) percentage from an expected 28 percent to just 8 percent for a biopharmaceutical company studying a drug for patients with insulin-dependent diabetes mellitus.

Published: 2005
Format: PDF
Length: 2 pages
Type: Case Study
Language: English
.
SPONSORED REPORTS
  • New intravenous drug therapies possible due to Microfluidizer processing
  • Helping cancer patients take their medicine
  • Implementing an infrared thermography maintenance program
  • Online auditing of alarm systems
  • Common hazardous waste issues in the life sciences industry
  • 5x return on investment in the pharmaceutical industry
  • ad

    KnowPharma.com Copyright © 2008, Putman Media, Inc. All rights reserved.
    Designated trademarks and brands are the property of their respective owners.
    Use of this web site constitutes acceptance of the KnowPharma.com Terms and Conditions and Privacy Policy.
    Site Map